ZA201302812B - Topical gel composition - Google Patents
Topical gel compositionInfo
- Publication number
- ZA201302812B ZA201302812B ZA2013/02812A ZA201302812A ZA201302812B ZA 201302812 B ZA201302812 B ZA 201302812B ZA 2013/02812 A ZA2013/02812 A ZA 2013/02812A ZA 201302812 A ZA201302812 A ZA 201302812A ZA 201302812 B ZA201302812 B ZA 201302812B
- Authority
- ZA
- South Africa
- Prior art keywords
- gel composition
- topical gel
- topical
- composition
- gel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40538210P | 2010-10-21 | 2010-10-21 | |
FR1058611A FR2966365B1 (en) | 2010-10-21 | 2010-10-21 | TOPICAL GEL COMPOSITION |
PCT/EP2011/068261 WO2012052478A2 (en) | 2010-10-21 | 2011-10-19 | Topical gel composition |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201302812B true ZA201302812B (en) | 2014-06-25 |
Family
ID=45065557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2013/02812A ZA201302812B (en) | 2010-10-21 | 2013-04-18 | Topical gel composition |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP2605753A2 (en) |
JP (1) | JP2013540142A (en) |
KR (1) | KR20130101552A (en) |
CN (1) | CN103313700A (en) |
AU (1) | AU2011317642A1 (en) |
BR (1) | BR112013009577A2 (en) |
CA (1) | CA2814975A1 (en) |
IL (1) | IL225775A0 (en) |
MX (1) | MX2013004472A (en) |
RU (1) | RU2013123043A (en) |
SG (1) | SG189338A1 (en) |
WO (1) | WO2012052478A2 (en) |
ZA (1) | ZA201302812B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2841632A1 (en) * | 2011-07-14 | 2013-01-17 | Allergan, Inc. | Gel compositions of oxymetazoline and methods of use |
CN104666239A (en) * | 2013-11-27 | 2015-06-03 | 杭州赛利药物研究所有限公司 | Brimonidine tartrate gel and preparation method thereof |
CN103919717A (en) * | 2014-04-15 | 2014-07-16 | 天津中医药大学 | Brimonidine d-tartrate ophthalmic gel preparation as well as preparation method and application thereof |
EP3476393A4 (en) * | 2016-06-28 | 2019-07-17 | Doris Maria Hexsel | Use of an active substance in the treatment of telangiectatic melasma |
AU2020264808A1 (en) | 2019-05-01 | 2021-11-04 | Clexio Biosciences Ltd. | Methods of treating pruritus |
CN110882211A (en) * | 2019-12-31 | 2020-03-17 | 深圳市瀚德标检生物工程有限公司 | Hydroxyphenyl ester gel and preparation method thereof |
CN116159018A (en) * | 2023-03-01 | 2023-05-26 | 中国药科大学 | Novel external brimonidine gel |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9006A (en) * | 1852-06-08 | Improvement in seed-planters | ||
US7439241B2 (en) | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
US20050020600A1 (en) | 2003-07-23 | 2005-01-27 | Scherer Warren J. | Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists |
CN101426502A (en) * | 2004-05-25 | 2009-05-06 | 桑斯罗萨医药发展公司 | Compounds, formulations, and methods for treating or preventing inflammatory skin disorders |
US20090061020A1 (en) * | 2007-08-31 | 2009-03-05 | Theobald Klaus P | Brimonidine Compositions for Treating Erythema |
KR101577471B1 (en) | 2007-11-16 | 2015-12-14 | 알러간, 인코포레이티드 | Compositions and methods for treating purpura |
CA2709199A1 (en) * | 2007-12-21 | 2009-07-02 | Galderma Laboratories, Inc. | Pre-surgical treatment |
JP5052558B2 (en) * | 2009-04-03 | 2012-10-17 | ロート製薬株式会社 | Gel ointment |
-
2011
- 2011-10-19 CA CA2814975A patent/CA2814975A1/en not_active Abandoned
- 2011-10-19 EP EP11771146.5A patent/EP2605753A2/en not_active Withdrawn
- 2011-10-19 AU AU2011317642A patent/AU2011317642A1/en not_active Abandoned
- 2011-10-19 RU RU2013123043/15A patent/RU2013123043A/en unknown
- 2011-10-19 SG SG2013026679A patent/SG189338A1/en unknown
- 2011-10-19 KR KR1020137012906A patent/KR20130101552A/en not_active Application Discontinuation
- 2011-10-19 WO PCT/EP2011/068261 patent/WO2012052478A2/en active Application Filing
- 2011-10-19 BR BR112013009577A patent/BR112013009577A2/en not_active IP Right Cessation
- 2011-10-19 JP JP2013534308A patent/JP2013540142A/en active Pending
- 2011-10-19 MX MX2013004472A patent/MX2013004472A/en unknown
- 2011-10-19 CN CN2011800509124A patent/CN103313700A/en active Pending
-
2013
- 2013-04-15 IL IL225775A patent/IL225775A0/en unknown
- 2013-04-18 ZA ZA2013/02812A patent/ZA201302812B/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL225775A0 (en) | 2013-09-30 |
AU2011317642A1 (en) | 2013-05-02 |
WO2012052478A3 (en) | 2012-06-14 |
JP2013540142A (en) | 2013-10-31 |
RU2013123043A (en) | 2014-12-10 |
KR20130101552A (en) | 2013-09-13 |
SG189338A1 (en) | 2013-05-31 |
EP2605753A2 (en) | 2013-06-26 |
MX2013004472A (en) | 2013-10-25 |
CN103313700A (en) | 2013-09-18 |
WO2012052478A2 (en) | 2012-04-26 |
BR112013009577A2 (en) | 2016-07-12 |
CA2814975A1 (en) | 2012-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201304286B (en) | Gel composition | |
GB201002983D0 (en) | Nutritinal composition | |
EP2566488A4 (en) | Povidone-iodine topical composition | |
EP2645983A4 (en) | Melanin promoting topical composition | |
GB0913255D0 (en) | Topical composition | |
GB201101733D0 (en) | Cosmetic composition | |
SI2444068T1 (en) | Brimonidine gel composition | |
ZA201400910B (en) | Gel composition | |
GB201020601D0 (en) | Topical formulation | |
ZA201302812B (en) | Topical gel composition | |
ZA201207330B (en) | Spray-pumpable composition suitable for topical skin application | |
HK1187537A1 (en) | Cosmetic composition | |
GB201021836D0 (en) | Topical Composition | |
EP2555784A4 (en) | Honey-based gel composition | |
IL229696A0 (en) | Gel compositions | |
EP2612650A4 (en) | Manicure composition | |
PL2450294T3 (en) | Gel applicator | |
GB201004717D0 (en) | Composition | |
GB201300858D0 (en) | Topical Composition | |
FR2966365B1 (en) | TOPICAL GEL COMPOSITION | |
PL390147A1 (en) | Cosmetic composition | |
GB201002356D0 (en) | Composition | |
GB201003348D0 (en) | Topical composition | |
GB201003350D0 (en) | Topical composition | |
IL225193A0 (en) | Foamable topical composition |